LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $367,400 | -52.0% | 337,064 | +0.8% | 0.00% | -50.0% |
| Q2 2023 | $765,435 | +51.2% | 334,251 | +60.4% | 0.00% | +33.3% |
| Q1 2023 | $506,249 | +97.0% | 208,333 | +54.8% | 0.00% | +200.0% |
| Q4 2022 | $257,004 | +55.8% | 134,557 | +178.9% | 0.00% | 0.0% |
| Q4 2020 | $165,000 | +3.8% | 48,249 | -56.2% | 0.00% | 0.0% |
| Q3 2020 | $159,000 | +12.8% | 110,263 | +55.5% | 0.00% | 0.0% |
| Q2 2020 | $141,000 | +65.9% | 70,911 | +62.3% | 0.00% | 0.0% |
| Q1 2020 | $85,000 | -78.8% | 43,700 | +7.7% | 0.00% | -50.0% |
| Q4 2017 | $401,000 | +158.7% | 40,575 | +222.7% | 0.00% | +100.0% |
| Q3 2017 | $155,000 | – | 12,575 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
| BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
| Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
| NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
| PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
| XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
| WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |